BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 22, 2018 | $750,000 | Replaced |
| 4th Quarter - Amendment (this page) | Sep 14, 2020 | $750,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Accounting ACC
Importation - Affordable and Safe Prescription Drug Importation Act- Sanders
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
Consumer Issues/Safety/Products CSP
Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
Animals ANI
Animal Health - The Animal Drug User Fee Act of 2003 (ADUFA),
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY BRIDGET WALSH New | Sen. Bill Nelson - Legislative Assistant, Deputy Legislative Director; Sen. Jon Tester - Legislative Director, Deputy Chief of Staff and Acting Chief of Staff |
Health Issues HCR
Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Resolution expressing support for the designation of November 9, 2017 as "National Diabetes Heart Connection Awareness Day."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
Medicare/Medicaid MMM
Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; IPAB (Independent Payment Advisory Board). Biosimilars and the Part D Coverage Gap Discount.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
Budget/Appropriations BUD
House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Non-Interference; and Drug Pricing. HR. 849 Protecting Seniors' Access to Medicare Act of 2017 (IPAB) Medicare S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN REA MCPHERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.